Dr Florent Baty
Leitende(r) Wissenschaftler/in
Pneumologie und Schlafmedizin · Dept. I
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
Baty F, Jörger M, Früh M, Klingbiel D, Zappa F, Brutsche M. 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling. J Transl Med 2017; 15:66.
30.03.201724h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
30.03.2017J Transl Med 2017; 15:66
Baty Florent, Jörger Markus, Früh Martin, Klingbiel Dirk, Zappa Francesco, Brutsche Martin
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
Feigelman R, Kahlert C, Baty F, Rassouli F, Kleiner R, Kohler P, Brutsche M, Von Mering C. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome 2017; 5:20.
10.02.2017Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
10.02.2017Microbiome 2017; 5:20
Feigelman Rounak, Kahlert Christian, Baty Florent, Rassouli Frank, Kleiner Rebekka L, Kohler Philipp, Brutsche Martin, Von Mering Christian
Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients
Gachechiladze M, Soltermann A, Weder W, Stahel R, Baty F, Kolář Z, Bouchal J, Langová K, Grygárková I, Kolek V, Škarda J, Jörger M. Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer 2017; 105:31-38.
18.01.2017Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients
18.01.2017Lung Cancer 2017; 105:31-38
Gachechiladze Mariam, Soltermann Alex, Weder Walter, Stahel Rolf, Baty Florent, Kolář Zdeněk, Bouchal Jan, Langová Kateřina, Grygárková Ivona, Kolek Vítězslav, Škarda Josef, Jörger Markus
Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Horvath C, Brutsche M, Schoch O, Schillig B, Baty F, vonOw D, Rüdiger J. Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2017; 12:1339.
01.01.2017Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
01.01.2017Intern Emerg Med 2017; 12:1339
Horvath Christian Michael, Brutsche Martin, Schoch Otto, Schillig Bernarde, Baty Florent, vonOw Dieter, Rüdiger Jochen Julius
Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
Baty F, van Gestel A, Kern L, Brutsche M. Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2016; 92:371-379.
09.11.2016Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
09.11.2016Respiration 2016; 92:371-379
Baty Florent, van Gestel Arnoldus J R, Kern Lukas, Brutsche Martin
Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis
Horvath C, Brutsche M, Baty F, Rüdiger J. Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis. Swiss Med Wkly 2016; 146:w14373.
26.10.2016Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis
26.10.2016Swiss Med Wkly 2016; 146:w14373
Horvath Christian Michael, Brutsche Martin, Baty Florent, Rüdiger Jochen
SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer
Putora P, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M. SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer. Oncol Res Treat 2016; 39:681-686.
19.10.2016SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer
19.10.2016Oncol Res Treat 2016; 39:681-686
Putora Paul Martin, Szentesi Kinga, Glatzer Markus, Rodriguez Regulo, Müller Joachim, Baty Florent, Früh Martin
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Horvath C, Brutsche M, Schoch O, Schillig B, Baty F, vonOw D, Rüdiger J. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016
Horvath Christian Michael, Brutsche Martin, Schoch Otto, Schillig Bernarde, Baty Florent, vonOw Dieter, Rüdiger Jochen
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Baty F. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016; 12:1215-1223.
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016; 12:1215-1223
Baty Florent
Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients
Rassouli F, Pfister M, Widmer S, Baty F, Burger B, Brutsche M. Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients. Respiration 2016; 92:107-13.
24.08.2016Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients
24.08.2016Respiration 2016; 92:107-13
Rassouli Frank, Pfister Maurus, Widmer Sandra, Baty Florent, Burger Barbara, Brutsche Martin
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Neumair P, Cerny T, Krähenbühl S, Baty F, Brutsche M, Früh M, Hitz F, Ess S, Dutly A, Warschkow R, Joos L, Jörger M. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer 2016; 100:38-44.
28.07.2016Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
28.07.2016Lung Cancer 2016; 100:38-44
Neumair P, Cerny Thomas, Krähenbühl S, Baty Florent, Brutsche Martin, Früh Martin, Hitz Felicitas, Ess S, Dutly A, Warschkow Rene, Joos L, Jörger Markus
Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models
Baty F, Ritz C, van Gestel A, Brutsche M, Gerhard D. Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models. BMC Med Res Methodol 2016; 16:66.
01.06.2016Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models
01.06.2016BMC Med Res Methodol 2016; 16:66
Baty Florent, Ritz Christian, van Gestel Arnoldus, Brutsche Martin, Gerhard Daniel
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
Cernomaz A, Brutsche M, Zonda R, Peter S, Baty F, Marinca M, Grigoriu C, Pavel I, Macovei I, Grigoriu B. Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment. BMC Pulm Med 2016; 16:88.
23.05.2016Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
23.05.2016BMC Pulm Med 2016; 16:88
Cernomaz Andrei-Tudor, Brutsche Martin, Zonda Radu, Peter Simona, Baty Florent, Marinca Mihai, Grigoriu Carmen, Pavel Ionut, Macovei Ina Iuliana, Grigoriu Bogdan- Dragos